IBDEI2J2 ; ; 04-FEB-2020
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 04, 2020
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,999) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,40357,1,4,0)
 ;;=4^D86.84
 ;;^UTILITY(U,$J,358.3,40357,2)
 ;;=^5002449
 ;;^UTILITY(U,$J,358.3,40358,0)
 ;;=D86.85^^152^2010^42
 ;;^UTILITY(U,$J,358.3,40358,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,40358,1,3,0)
 ;;=3^Sarcoid Myocarditis
 ;;^UTILITY(U,$J,358.3,40358,1,4,0)
 ;;=4^D86.85
 ;;^UTILITY(U,$J,358.3,40358,2)
 ;;=^5002450
 ;;^UTILITY(U,$J,358.3,40359,0)
 ;;=D86.83^^152^2010^40
 ;;^UTILITY(U,$J,358.3,40359,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,40359,1,3,0)
 ;;=3^Sarcoid Iridocyclitis
 ;;^UTILITY(U,$J,358.3,40359,1,4,0)
 ;;=4^D86.83
 ;;^UTILITY(U,$J,358.3,40359,2)
 ;;=^5002448
 ;;^UTILITY(U,$J,358.3,40360,0)
 ;;=D84.1^^152^2010^16
 ;;^UTILITY(U,$J,358.3,40360,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,40360,1,3,0)
 ;;=3^Defects in Complement System
 ;;^UTILITY(U,$J,358.3,40360,1,4,0)
 ;;=4^D84.1
 ;;^UTILITY(U,$J,358.3,40360,2)
 ;;=^5002439
 ;;^UTILITY(U,$J,358.3,40361,0)
 ;;=D81.810^^152^2010^5
 ;;^UTILITY(U,$J,358.3,40361,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,40361,1,3,0)
 ;;=3^Biotinidase Deficiency
 ;;^UTILITY(U,$J,358.3,40361,1,4,0)
 ;;=4^D81.810
 ;;^UTILITY(U,$J,358.3,40361,2)
 ;;=^5002422
 ;;^UTILITY(U,$J,358.3,40362,0)
 ;;=E88.01^^152^2010^2
 ;;^UTILITY(U,$J,358.3,40362,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,40362,1,3,0)
 ;;=3^Apha-1 Antitrypsin Deficiency
 ;;^UTILITY(U,$J,358.3,40362,1,4,0)
 ;;=4^E88.01
 ;;^UTILITY(U,$J,358.3,40362,2)
 ;;=^331442
 ;;^UTILITY(U,$J,358.3,40363,0)
 ;;=J09.X1^^152^2010^25
 ;;^UTILITY(U,$J,358.3,40363,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,40363,1,3,0)
 ;;=3^Influenza d/t Indent Novel Influenza A Virus w/ Pneumonia
 ;;^UTILITY(U,$J,358.3,40363,1,4,0)
 ;;=4^J09.X1
 ;;^UTILITY(U,$J,358.3,40363,2)
 ;;=^5008144
 ;;^UTILITY(U,$J,358.3,40364,0)
 ;;=J09.X2^^152^2010^26
 ;;^UTILITY(U,$J,358.3,40364,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,40364,1,3,0)
 ;;=3^Influenza d/t Indent Novel Influenza A Virus w/ Resp Manifest
 ;;^UTILITY(U,$J,358.3,40364,1,4,0)
 ;;=4^J09.X2
 ;;^UTILITY(U,$J,358.3,40364,2)
 ;;=^5008145
 ;;^UTILITY(U,$J,358.3,40365,0)
 ;;=J09.X3^^152^2010^27
 ;;^UTILITY(U,$J,358.3,40365,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,40365,1,3,0)
 ;;=3^Influenza d/t Indent Novel Influenza A Virus w/ GI Manifest
 ;;^UTILITY(U,$J,358.3,40365,1,4,0)
 ;;=4^J09.X3
 ;;^UTILITY(U,$J,358.3,40365,2)
 ;;=^5008146
 ;;^UTILITY(U,$J,358.3,40366,0)
 ;;=J09.X9^^152^2010^28
 ;;^UTILITY(U,$J,358.3,40366,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,40366,1,3,0)
 ;;=3^Influenza d/t Indent Novel Influenza A Virus w/ Oth Manifest
 ;;^UTILITY(U,$J,358.3,40366,1,4,0)
 ;;=4^J09.X9
 ;;^UTILITY(U,$J,358.3,40366,2)
 ;;=^5008147
 ;;^UTILITY(U,$J,358.3,40367,0)
 ;;=J44.9^^152^2010^14
 ;;^UTILITY(U,$J,358.3,40367,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,40367,1,3,0)
 ;;=3^COPD,Unspec
 ;;^UTILITY(U,$J,358.3,40367,1,4,0)
 ;;=4^J44.9
 ;;^UTILITY(U,$J,358.3,40367,2)
 ;;=^5008241
 ;;^UTILITY(U,$J,358.3,40368,0)
 ;;=J44.1^^152^2010^12
 ;;^UTILITY(U,$J,358.3,40368,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,40368,1,3,0)
 ;;=3^COPD w/ Acute Exacerbation
 ;;^UTILITY(U,$J,358.3,40368,1,4,0)
 ;;=4^J44.1
 ;;^UTILITY(U,$J,358.3,40368,2)
 ;;=^5008240
 ;;^UTILITY(U,$J,358.3,40369,0)
 ;;=J42.^^152^2010^10
 ;;^UTILITY(U,$J,358.3,40369,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,40369,1,3,0)
 ;;=3^Bronchitis,Unspec Chronic
 ;;^UTILITY(U,$J,358.3,40369,1,4,0)
 ;;=4^J42.
